Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2025-12-24 @ 10:47 PM
Study NCT ID:
NCT03190369
Status:
COMPLETED
Last Update Posted:
2022-03-25
First Post:
2017-06-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Randomized Study of the Efficacy and Safety of a Single Dose of Synvisc-One® in Chinese Patients With Symptomatic Osteoarthritis of the Knee
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-14
First Submit QC Date:
None
Study First Post Date:
2017-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-01-19
Results First Submit QC Date:
None
Results First Post Date:
2020-02-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-15
Last Update Post Date:
2022-03-25
Last Update Post Date Type:
ACTUAL